520 related articles for article (PubMed ID: 27628004)
1. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
Islam MS
Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
[TBL] [Abstract][Full Text] [Related]
2. Systemic thrombolysis for acute pulmonary embolism.
Bartel B
Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy for pulmonary embolism.
Katchan BM
Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
[TBL] [Abstract][Full Text] [Related]
4. Systemic thrombolysis in pulmonary embolism - another paradigm falling?
Freisinger E; Reinecke H
Vasa; 2015 Mar; 44(2):156. PubMed ID: 25698395
[No Abstract] [Full Text] [Related]
5. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
Tapson VF; Friedman O
Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
[TBL] [Abstract][Full Text] [Related]
6. [Fibrinolysis in pulmonary embolism].
Thabut G; Jebrak G
Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
Bethea BT; Elliot JW; Richardson JB; Ahmed MI
Am J Health Syst Pharm; 2017 Aug; 74(15):1153-1157. PubMed ID: 28743779
[TBL] [Abstract][Full Text] [Related]
8. Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism.
Güner A; Kalçik M; Aykan AÇ; Gürsoy MO; Kalkan AK; Astarcioğlu MA; Ertürk M; Uzun F; Güner EG; Yildiz M; Özkan M
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):536-542. PubMed ID: 33181758
[TBL] [Abstract][Full Text] [Related]
9. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
Rothschild DP; Goldstein JA; Bowers TR
Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.
Bagla S; Smirniotopoulos JB; van Breda A; Sheridan MJ; Sterling KM
J Vasc Interv Radiol; 2015 Jul; 26(7):1001-6. PubMed ID: 25704224
[TBL] [Abstract][Full Text] [Related]
11. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
Long B; Koyfman A
J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.
Mohan PP; Manov JJ; Contreras F; Langston ME; Doshi MH; Narayanan G
Vasc Endovascular Surg; 2018 Apr; 52(3):195-201. PubMed ID: 29436310
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
[TBL] [Abstract][Full Text] [Related]
14. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
Mele M; Mele A; La Torre PP; Cannone M
G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
[TBL] [Abstract][Full Text] [Related]
15. Life-saving systemic thrombolysis in a patient with massive pulmonary embolism and a recent hemorrhagic cerebrovascular accident.
Bottinor W; Turlington J; Raza S; Roberts CS; Malhotra R; Jovin IS; Abbate A
Tex Heart Inst J; 2014 Apr; 41(2):174-6. PubMed ID: 24808778
[TBL] [Abstract][Full Text] [Related]
16. Should thrombolytic therapy be used in patients with pulmonary embolism?
Konstantinides S
Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719
[TBL] [Abstract][Full Text] [Related]
17. [Thrombolytic therapy in pulmonary embolism. Indications and therapeutic strategies].
Niedermeyer J; Meissner E; Fabel H
Z Gesamte Inn Med; 1993; 48(6-7):332-43. PubMed ID: 8333230
[TBL] [Abstract][Full Text] [Related]
18. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis.
Kabrhel C; Ali A; Choi JG; Hur C
Acad Emerg Med; 2017 Oct; 24(10):1235-1243. PubMed ID: 28650086
[TBL] [Abstract][Full Text] [Related]
19. Massive pulmonary embolism in a young boy with T-cell leukaemia. Successful thrombolytic therapy by recombinant tissue plasminogen activator (rtPA).
Beck O; Martin C; Alt F; Wingerter A; Staatz G; Schinzel H; Faber J
Hamostaseologie; 2014; 34(3):233-6. PubMed ID: 24975773
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism.
Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G
Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
